Oncology & Cancer
Genetically modified cells learn to fight mesothelioma
It's been called the "fifth pillar" of cancer treatment: genetically re-engineering the human immune system to recognize cancers and fight them.
Nov 6, 2014
0
0
Mesothelioma
Oncology & Cancer
Novel cancer vaccine holds promise against ovarian cancer, mesothelioma
A novel approach to cancer immunotherapy – strategies designed to induce the immune system to attack cancer cells – may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian ...
Mar 5, 2014
0
0
Oncology & Cancer
Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma
A common Asian spice and cancer-hampering molecules show promise in slowing the progression of mesothelioma, a cancer of the lung's lining often linked to asbestos. Scientists from Case Western Reserve University and the ...
Sep 18, 2014
0
0
Diseases, Conditions, Syndromes
Idiopathic pulmonary fibrosis cases linked with asbestos exposure
A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study. If confirmed, the findings would mean that current treatment strategies need to be altered ...
Sep 9, 2014
0
0
Medical research
Exhaled breath analysis shows promise in detecting malignant pleural mesothelioma
Identifying and analyzing volatile organic compounds in exhaled breath of patients with malignant pleural mesothelioma showed promise as a screening method for MPM, according to research presented today at the International ...
Sep 9, 2023
0
16
Medications
Clinical trial shows tumor-starving drug improves survival of mesothelioma
Peter Szlosarek, Professor of Medical Oncology at Queen Mary's Barts Cancer Institute, presented his team's results from the ATOMIC-Meso clinical trial in partnership with Polaris Pharmaceuticals, Inc., at the American Association ...
Apr 18, 2023
0
15
Medications
Triple combination therapy shows promise against a rare, deadly asbestos cancer
Combining immune-boosting drugs with radiation and surgery increased the survival and anticancer immune response in mouse models of mesothelioma in preclinical research by Princess Margaret Cancer Centre researchers.
Apr 14, 2021
0
83
Oncology & Cancer
Combination therapy shows promise for rare, deadly cancer caused by asbestos
Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy ...
Jun 2, 2011
0
0
Health
Team publishes landmark asbestos study
A landmark study from The Australian National University (ANU) into the health impacts of living in a house with loose-fill asbestos insulation has been published in the international journal The Lancet Public Health.
Nov 2, 2017
0
49
Oncology & Cancer
Aspirin may delay growth of asbestos-related cancer
Aspirin may inhibit the growth of mesothelioma, an aggressive and deadly asbestos-related cancer, University of Hawai'i Cancer Center researchers have found.
Jul 7, 2015
0
53
